 |
|
 |
      
|
Steven H. Ferris, Ph.D. Executive Director
Expanding initial research that evaluated pharmacologic treatments for Alzheimer's disease into a comprehensive, multidisciplinary research center studying cognitive decline in aging and dementia, Dr. Ferris has now contributed more than 250 scientific publications to the field. Current research interests include clinical trials in aging and Alzheimer’s Disease, the development of improved diagnostic and outcome measures, particularly neuropsychological techniques for early diagnosis, and the study of psychosocial methods for improving the well-being of Alzheimer's caregivers. During the past decade, he has contributed to the recognition of Mild Cognitive Impairment (MCI) as a very early stage of Alzheimer’s disease and as an important target for early treatment. Dr. Ferris is the Associate Editor in Chief of Alzheimer Disease and Associated Disorders, is a member of the Medical and Scientific Affairs Council of the national Alzheimer’s Association, has served on several NIH peer review panels, and has been a member of the FDA Advisory Committee which reviews new drugs for Alzheimer disease.
|
|
About
the ADRC| For Patients & Families
| For Professionals | Programs
& Services
|
|
 Silberstein Aging & Dementia Research Center New York University School of Medicine © 2002 New York University Ethics and Disclaimer |
  |
 |
 |
 |
Steven
H. Ferris, Ph.D., is a neuropsychologist, psychopharmacologist, and
gerontologist who has been studying aging and Alzheimer disease for
more than twenty-five years. Currently, Dr. Ferris is Executive Director
of the NYU Silberstein Aging and Dementia Research Center, Principal
Investigator of their NIA-supported Alzheimer’s Disease Center,
and Professor at the Department of Psychiatry at New York University
School of Medicine.
